⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BCTXW News

BriaCell Therapeutics Corp. Warrant

BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients